Malaria Consortium

What Malaria Consortium does

Malaria Consortium is a UK-registered non-governmental organisation and global health charity founded in 2003, specialising in the prevention, control and treatment of malaria and associated diseases in low- and middle-income countries. Headquartered in London with regional offices in Kampala, Abuja and Bangkok, it operates programmes across 12 countries in Africa and Asia — Burkina Faso, Cambodia, Chad, Ethiopia, Mozambique, Myanmar, Nigeria, South Sudan, Thailand, Togo and Uganda — delivered through partnerships with national ministries of health, national malaria control programmes, and a network of community health workers, with staff predominantly national to the countries served.

Its core portfolio centres on seasonal malaria chemoprevention (SMC), where it is the world's leading implementer reaching over half of all targeted children globally; perennial malaria chemoprevention (PMC); mass insecticide-treated net distribution; integrated community case management; and malaria molecular surveillance to track drug and diagnostic resistance. Supporting these are digital health platforms including upSCALE (Mozambique), DIGIT HCM (co-developed with Catholic Relief Services and eGov Foundation) for campaign management, and a forthcoming open data platform with individual-patient data repository. Research is institutionalised through its Independent Research Organisation status awarded by UKRI in 2021.

Malaria Consortium does not sell products or services in a commercial sense. It is funded through a diversified donation and grant model: individual donations in multiple currencies, corporate and foundation philanthropy, government and institutional grants channelled through Malaria Consortium (UK), and the 501(c)(3) affiliate Malaria Consortium US, which since 2019 has awarded 56 grants totalling $36.6M. Additional credibility comes from the GiveWell top-charity designation, Candid Platinum Seal, IATI compliance, and UK Fundraising Regulator membership. Leadership rests with Chief Executive Dr James Tibenderana and a Board of Trustees.

Name

Malaria Consortium

Legal name

Malaria Consortium

Website

https://malariaconsortium.org

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Malaria Consortium is a UK-registered global health charity founded in 2003 that prevents, controls and treats malaria and associated diseases across 12 African and Asian countries, delivering seasonal chemoprevention, net distribution, molecular surveillance and digital health tools in partnership with governments.

Ownership category

akta.pro rank

Product category

Global Health / Malaria Prevention Services

NAICS

Business, Professional, Labor, Political, and Similar Organizations (8139), Civic and Social Organizations (813410)

SIC

Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Disease-Specific Global Programs (HIV/TB/Malaria/NTDs) (HLAJAKAF)

akta.pro secondary industries

International & Local Implementing NGOs (HLAJAKAD), Global Health Research, Clinical Trials & Product Development Partnerships (PDPs) (HLAJAOAM), Communicable Disease Prevention & Control (HIV/AIDS, TB, Malaria, NTDs) (BPADAIAA)

Keywords

• Malaria prevention programmes
• Seasonal malaria chemoprevention
• Insecticide-treated net distribution
• Community case management
• Global health implementation

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Individual Donations: Malaria Consortium receives donations from individuals worldwide through its website, with options for one-time, monthly, and yearly donations in multiple currencies (GBP, EUR, AUD, CAD, USD).
2. Organizational Philanthropy and Corporate Donations: Funding from companies, trusts, foundations, and Donor Advised Funds for expanding scalable malaria and health equity programmes.
3. Malaria Consortium US Grants: MC-US, a registered 501(c)(3) entity, awards grants to Malaria Consortium projects. Since 2019, MC-US has awarded 56 grants totalling $36.6M to advance impactful global health initiatives.
4. Government and Institutional Grants: Funding from governments and institutional donors to support implementation of health programmes in malaria-endemic countries.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels9 records

Core offering

Malaria Consortium is a non-profit organisation that designs and delivers evidence-based malaria prevention, diagnosis, treatment, and surveillance interventions, including seasonal malaria chemoprevention (SMC), perennial malaria chemoprevention (PMC), insecticide-treated net (ITN) distribution, and digital health platforms. Programmes are implemented in partnership with ministries of health and national malaria control programmes across 12 countries in Africa and Asia, supported by operational research, surveillance, and capacity building for community health workers.

Product overview

Malaria Consortium operates as a global health charity offering a portfolio of malaria prevention, treatment, and surveillance interventions rather than a unified software product. The core offerings include Seasonal Malaria Chemoprevention (SMC) and Perennial Malaria Chemoprevention (PMC) programmes that deliver preventive medication to children, combined with insecticide-treated net distribution campaigns. These are complemented by digital health platforms (upSCALE, DIGIT HCM) that support community health workers and campaign management, alongside research services like Malaria Molecular Surveillance that track drug resistance. Additional interventions include arbovirus preparedness projects, climate-driven outbreak forecasting (FORECAST), and an open data repository for health data analysis. The portfolio works as integrated health programmes delivered in partnership with governments across 12 countries in Africa and Asia.

Differentiator

Problem solved

Functional benefit

Brands

• Dr Sylvia Meek Scholarship for Entomology: Established in 2016, supports aspiring entomologists from across the world to study at universities in Nigeria, South Africa and Thailand to advance evidence and thinking on disease prevention, control and elimination.

Products and services

• Seasonal Malaria Chemoprevention (SMC) Programme Preventive malaria medication delivered to children during rainy seasons in Sahel region countries; Malaria Consortium is the world's leading implementer of SMC, reaching over half of all targeted children globally.
• Perennial Malaria Chemoprevention (PMC) Year-round preventive malaria medication for infants and young children in areas with perennial malaria transmission, with scale-up in Osun State, Nigeria.
• Insecticide-Treated Net Distribution Mass distribution campaigns of long-lasting insecticidal nets (LLINs) for malaria prevention, with monitoring and evaluation of net access, use and attrition.
• Malaria Molecular Surveillance Genetic characterisation of malaria parasites to detect and monitor drug and diagnostic resistance patterns across populations, including in refugee populations in Uganda.
• upSCALE Digital Health Platform Digital health platform for community health workers in Mozambique that supports health campaigns and immunisation delivery through mobile technology.
• TRACK (Thailand Radical Cure Kit) Implementation research project evaluating a tailored radical cure intervention to treat malaria and prevent relapse in communities on the Thai-Myanmar border.
• FORECAST (Forecasting Outbreak Risks from Extreme Climate) Project using climate data and active surveillance technology to improve early warning systems for mosquito-borne disease outbreaks in Uganda.
• Data Platform and Patient Data Repository Open data platform and individual-patient data repository enabling researchers and programme implementers to analyse and reuse health data.
• DIGIT HCM (Digital Immunisation and Geospatial Tool for Health Campaigns Management) Digital public infrastructure tool for health campaign management, enabling campaign digitisation across public health interventions, developed with Catholic Relief Services and eGov Foundation.
• SARMAAN II Safety and antimicrobial resistance study of mass administration of azithromycin in children, scaling up MDA-AZM across 11 states in Nigeria.

Quantifiable outcome

• 32 million mosquito nets distributed (2021-2025)
• +7 more outcomes

Named customers3 records

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature3 records

Partnerships

Eleven partnerships are on record, tiered core, major and secondary.

• Catholic Relief ServicescoreStrategic or Co-development PartnerPartnership with Catholic Relief Services and eGov Foundation to host a session at ICT4D 2026 conference, showcasing the Digital Immunisation and Geospatial Tool for Health Campaigns Management (DIGIT HCM) and presenting use cases on leveraging digital public infrastructure for campaign digitisation.
• eGov FoundationcoreTechnology or IntegrationJoint development of digital tools including DIGIT HCM for health campaign management, leveraging digital public infrastructure to scale campaign digitisation across public health interventions in Nigeria.
• South Sudan National Ministry of HealthcoreStrategic or Co-development PartnerPartnership with South Sudan's National Ministry of Health and National Malaria Control Programme to release research findings on drug and diagnostic resistance, with results incorporated into South Sudan's National Malaria Strategic Plan.
• Malaria Consortium US BoardcoreStrategic or Co-development PartnerIndependent volunteer Board that awards grants to Malaria Consortium projects. Since 2019, has awarded 56 grants totalling $36.6M to advance global health initiatives.
• RBM Partnership to End MalariamajorStrategic or Co-development PartnerCEO of RBM Partnership to End Malaria visited Nigeria to celebrate significant decline in malaria prevalence, demonstrating progress towards elimination.
• World Health Organization (WHO)majorStrategic or Co-development PartnerWHO participated in dissemination meetings and co-design workshops for South Sudan drug resistance research findings.
• UNICEFmajorStrategic or Co-development PartnerUNICEF participated in dissemination meetings for South Sudan drug resistance research findings.
• Behavioural Insights Team (BIT)secondaryStrategic or Co-development PartnerPartnership to design and test interventions that close the gap between availability and use of insecticide-treated nets.
• Governments of Endemic CountriescoreStrategic or Co-development PartnerClose collaboration with ministries of health, national malaria control programmes, and local/sub-national authorities to implement and sustain health programmes.
• Academic InstitutionsmajorStrategic or Co-development PartnerPartnerships to translate research findings into practice and deliver cost-effective programmes, leveraging academic expertise.
• Civil Society OrganizationsmajorChannel Partner/ Reseller/ DistributorPartnership with civil society organizations to extend reach and delivery of health programmes to communities.

Scale indicators12 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• Against Malaria Foundation: Funds and tracks long-lasting insecticidal net (LLIN) distribution — the same core vector-control product (32M nets distributed by Malaria Consortium). GiveWell top-rated, hyper-focused on malaria prevention, direct operational and funding overlap.
• Population Services International (PSI): Global health implementing NGO with extensive malaria case management, SMC, and net distribution programmes across Africa and Asia, funded by US/UK bilateral and private donors. Comparable scale, geography, and intervention mix.
• Clinton Health Access Initiative (CHAI): Operates malaria programmes across Africa and Asia including SMC, case management, and surveillance; works directly with ministries of health. Closest comparable NGO in scale, intervention mix, and government-partnership GTM.
• FHI 360: Implements malaria prevention and treatment programmes funded by USAID/PMI across Africa and Asia; similar intervention mix (nets, SMC, case management), comparable staff scale, and same donor set as Malaria Consortium.

Broad incumbents

• PATH: Global health NGO with broader portfolio (vaccines, NTDs, malaria) including malaria product development and surveillance; similar revenue scale and donor base; overlapping but wider mandate.
• Médicins Sans Frontières (MSF): Operates malaria treatment programmes in conflict-affected and endemic countries including Nigeria, South Sudan, and Myanmar; shares operational geography and community-level delivery model but operates more broadly across diseases.
• Global Fund to Fight AIDS, Tuberculosis and Malaria: The largest multilateral financier of malaria programmes globally; operates as a funder rather than implementer (Malaria Consortium is a recipient), but is the dominant counterparty shaping Malaria Consortium's addressable funding pool.
• UNICEF Supply Division: Procures and distributes SMC medicines, LLINs, and RDTs at scale globally; operates both as a UN system procurement house and as an implementing partner in malaria-endemic countries. Overlaps with Malaria Consortium in supply chain and last-mile distribution.

Others

• RBM Partnership to End Malaria: Global coordination and advocacy partnership of which Malaria Consortium is an active partner; not a direct competitor but a central node in the malaria donor and policy ecosystem that channels funding and shapes priorities relevant to Malaria Consortium's programmes.

Regional players

• International Rescue Committee (IRC): Operates health programmes in malaria-endemic and conflict-affected African countries (Nigeria, South Sudan, Ethiopia, etc.); comparable NGO operating model with similar funding mix but broader health-and-humanitarian remit.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key highlights6 records

Customer concentration

• Xtwitter.com/MalariaConsortium
• YouTubeyoutube.com/channel/UCprd6Er7SO0ZM9L0B0Q3W7w
• LinkedInlinkedin.com/company/malaria-consortium
• Facebookfacebook.com/malariaconsortium

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Malaria Consortium